Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant patients: implications for clinical trials

Domingos, J; Eagle, M; Moraux, A; Butler, J; Decostre, V; Ridout, D; Mayhew, A; Selby, V; Guglieri, M; Van der Hoist, M; Jansen, M; Verschuuren, J; de Groot, I; Niks, E; Servais, L; Hogrel, JY; Straub, V; Voit, T; Ricotti, V; Muntoni, F

NEUROMUSCULAR DISORDERS, 2017; 27 ( ): S232